Real-world efficiency of pharmacogenetic screening for carbamazepine-induced severe cutaneous adverse reactions.
<h4>Objectives</h4>We evaluated the cost and efficiency of routine HLA-B*15 ∶ 02 screening to prevent carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis (CBZ-SJS/TEN) in Hong Kong.<h4>Methods</h4>Data were extracted from patients who commenced CBZ a...
Guardado en:
Autores principales: | Zhibin Chen, Danny Liew, Patrick Kwan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/60c1a95d0888499dbda5503d5f24e8f6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacogenetics to Avoid Adverse Reactions in Cardiology: Ready for Implementation?
por: Xandra García-González, et al.
Publicado: (2021) -
Severe cutaneous adverse reactions to drugs: a case series study
por: Clarisse F. CASTRO, et al.
Publicado: (2020) -
Identification of drug-specific public TCR driving severe cutaneous adverse reactions
por: Ren-You Pan, et al.
Publicado: (2019) -
Dermoscopic Aspects of Cutaneous Adverse Drug Reactions
por: Gabriela Rossi, et al.
Publicado: (2021) -
Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings
por: Maciel A, et al.
Publicado: (2018)